Abstract
“Head-to-side-chain” cyclic tripeptides were designed as endothelin receptor antagonists. Solid phase synthesis of cyclic peptides, using an automated allyl cleavage procedure with Pd[P(Ph 3)] 4 followed by cyclization was performed. Synthetic procedures were established on a continous-flow peptide synthesizer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
